Cancer Prevalence

U.S. cancer prevalence estimates for 2010 and projections for 2020 under different assumptions of cancer incidence and survival trends:

  • Base case assumes constant incidence and survival
  • Trend incidence assumes projected incidence trend and constant survival
  • Trend survival assumes constant incidence and projected survival trend
  • Trend incidence & survival assumes projected incidence and survival trends
  • Percent change from 2010 base estimate


Number of Cancer Survivors 1
  2010 Assumption for 2020 Projection
    Base Trend incidence Trend survival Trend incidence & survival
Site Base No. % change No. % change No. % change No. % change
Bladder 514,000 629,000 22% 576,000 12% 640,000 25% 587,000 14%
Brain 139,000 176,000 27% 174,000 25% 185,000 33% 182,000 31%
Breast (female) 3,461,000 4,538,000 31% 4,275,000 24% 4,597,000 33% 4,329,000 25%
Cervix 281,000 276,000 -2% 245,000 -13% 277,000 -1% 245,000 -13%
Colorectal 1,216,000 1,517,000 25% 1,327,000 9% 1,575,000 30% 1,376,000 13%
Esophagus 35,000 50,000 43% 48,000 37% 62,000 77% 60,000 71%
Head/Neck 283,000 340,000 20% 308,000 9% 346,000 22% 313,000 11%
Kidney 308,000 426,000 38% 487,000 58% 446,000 45% 511,000 66%
Leukemia 263,000 340,000 29% 328,000 25% 356,000 35% 342,000 30%
Lung 374,000 457,000 22% 392,000 5% 481,000 29% 412,000 10%
Lymphoma 639,000 812,000 27% 803,000 26% 841,000 32% 831,000 30%
Melanoma 1,225,000 1,714,000 40% 1,971,000 61% 1,724,000 41% 1,983,000 62%
Ovary 238,000 282,000 18% 232,000 -3% 296,000 24% 241,000 1%
Pancreas 30,000 40,000 33% 40,000 33% 50,000 67% 50,000 67%
Prostate 2,311,000 3,265,000 41% 3,108,000 34% 3,291,000 42% 3,132,000 36%
Stomach 74,000 93,000 26% 80,000 8% 103,000 39% 88,000 19%
Uterus 586,000 672,000 15% 638,000 9% 667,000 14% 634,000 8%
All Sites 13,772,000 18,071,000 31% 17,465,000 27% 18,878,000 37% 18,229,000 32%